E-LIB Suche - Ergebnisse für: Xu, Chong-Rui

1

PD-L1 expression guidance on sintilimab versus pembrolizuma..:

Maggie Liu, Si-Yang ; Huang, Jie ; Deng, Jia-Yi...
Science Bulletin. 69 (2024) 4 - p. 535-543 , 2024

Link: https://doi.org/10.1016/..

2

Redoxhighphenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mut..:

Wei, Xue-Wu ; Lu, Chang ; Zhang, Yi-Chen...
OncoImmunology. 13 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

3

Plasma ddPCR for the detection of MET amplification in adva..:

Su, Jun-Wei ; Weng, Cheng-Di ; Lin, Xiao-Cheng...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

4

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSC..:

Zhang, Chao ; Sun, Yu-Xuan ; Yi, Ding-Cheng...
Cell Reports Medicine. , 2024

Link: https://doi.org/10.1016/..

5

Allelic Context of EGFR C797X–Mutant Lung Cancer Defines Fo..:

Lu, Chang ; Wei, Xue-Wu ; Wang, Zhen...
Journal of Thoracic Oncology. 19 (2024) 4 - p. 601-612 , 2024

Link: https://doi.org/10.1016/..

6

Correlation of distribution characteristics and dynamic cha..:

Luo, Wei-Chi ; Mei, Shi-Qi ; Huang, Zi-Jian...
Journal of Translational Medicine. 22 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

7

Association of COVID-19 and Lung Cancer: Short-Term and Lon..:

Peng, Ying-Long ; Wang, Zi-Yan ; Zhong, Ri-Wei...
Cancers. 16 (2024) 2 - p. 304 , 2024

Link: https://doi.org/10.3390/..

8

First-line pyrotinib in advanced HER2-mutant non-small-cell..:

Liu, Si-Yang Maggie ; Tu, Hai-Yan ; Wei, Xue-Wu...
Nature Medicine. , 2023

Link: https://doi.org/10.1038/..

9

Efficacy, safety and dose selection of AZD3759 in patients ..:

Maggie Liu, Si-Yang ; Dong, Xiao-Rong ; Wang, Zhen...
eClinicalMedicine. 64 (2023) - p. 102238 , 2023

Link: https://doi.org/10.1016/..

10

Using patient-derived organoids to predict locally advanced..:

Wang, Han-Min ; Zhang, Chan-Yuan ; Peng, Kai-Cheng...
Cell Reports Medicine. 4 (2023) 2 - p. 100911 , 2023

Link: https://doi.org/10.1016/..

11

Dynamic circulating tumor DNA during chemoradiotherapy pred..:

Pan, Yi ; Zhang, Jia-Tao ; Gao, Xuan...
Cancer Cell. 41 (2023) 10 - p. 1763-1773.e4 , 2023

Link: https://doi.org/10.1016/..

12

Immune suppressive microenvironment in liver metastases con..:

Deng, Jia-Yi ; Gou, Qing ; Yang, Lingling...
Journal for ImmunoTherapy of Cancer. 11 (2023) 7 - p. e007218 , 2023

Link: https://doi.org/10.1136/..

13

A potential treatment option for transformed small-cell lun..:

Zhang, Chan-Yuan ; Sun, Hao ; Su, Jun-Wei...
Lung Cancer. 175 (2023) - p. 68-78 , 2023

Link: https://doi.org/10.1016/..

14

Selective RET inhibitors shift the treatment pattern of RET..:

Lu, Chang ; Wei, Xue-Wu ; Zhang, Yi-Chen...
Journal of Cancer Research and Clinical Oncology. 149 (2022) 7 - p. 2987-2995 , 2022

Link: https://doi.org/10.1007/..

15

Overall survival with circulating tumor DNA-guided therapy ..:

Jee, Justin ; Lebow, Emily S. ; Yeh, Randy...
Nature Medicine. 28 (2022) 11 - p. 2353-2363 , 2022

Link: https://doi.org/10.1038/..